logo
CNBC Daily Open: Headwinds don't seem to bother the U.S. stock market

CNBC Daily Open: Headwinds don't seem to bother the U.S. stock market

CNBCa day ago

The U.S. stock market appears a little too optimistic. All three major indexes climbed Wednesday, with the S&P 500 and Nasdaq Composite enjoying their third consecutive session in the green. The S&P, in fact, is around 2% away from its all-time high, which it reached in February.
That's despite the shadow of U.S. President Donald Trump's "reciprocal" tariffs still haunting the economy. As the 90-day tariff pause ticks down, America, so far, has just one deal, struck with the U.K., and an agreement with China that, while reaffirmed by both sides after two days of negotiations in London, is still preliminary and keeps tariffs at double-digit levels.
Corporations are seemingly bracing for economic fallout already. Layoffs have been accelerating this year. Google and Paramount on Tuesday joined Microsoft, Citigroup and Disney in announcing headcount cuts. (However, it should be noted that layoffs, rather perversely, tend to push up stock prices because they are a cost-cutting measure.)
And the bond market, the sterner sibling of the stock market, might put a check on investor enthusiasm. If there are unexpected results from U.S. inflation data and Treasury auctions on Wednesday and Thursday, yields could rise again, not only putting pressure on stocks, but also the broader economy in terms of higher borrowing costs.
The stock market, then, seems to be betting on more trade breakthroughs and favorable inflation data. But the bond market and CEOs might not be so sure about that.
U.S. and China reach trade frameworkThe U.S. and China have reached an agreement on trade, representatives from both sides said Tuesday after a second day of high-level talks in London. The deal now awaits a nod from the leaders of the two countries. U.S. Commerce Secretary Howard Lutnick indicated U.S. restrictions on sales of advanced tech to China in recent weeks would be rolled back as Beijing approves rare-earth exports.
S&P 500 notches three-day win streakU.S. stocks rose Wednesday. The S&P 500 advanced 0.55% and the Nasdaq Composite climbed 0.63%, the third day of gains for both indexes. The Dow Jones Industrial Average added 0.25%. Asia-Pacific markets climbed Wednesday on optimism surrounding U.S.-China trade talks. Hong Kong's Hang Seng Index added 0.92% and mainland China's CSI 300 rose 0.77% at 1:30 p.m. Singapore time. Meanwhile, South Korea's Kospi was up 1%, hitting its highest level since January 2022.
Musk announces robotaxi launchElon Musk said Tuesday Tesla's robotaxi service is "tentatively" set to launch in Austin, Texas, on June 22. Earlier in the day, Tesla shares rose 5.7% to close at $326.09, leaving the stock about $6 short of where it was trading last Wednesday, when it sank 14% after CEO Musk publicly feuded with Trump. The jump came after Musk shared a video on X showing that Tesla was testing driverless vehicles on the roads of Austin.
Bond market in focus The U.S. Bureau of Labor Statistics releases data on May's consumer prices on Wednesday, then producer prices on Thursday. At the same time, the government will hold sales of long-duration Treasurys on the same days. Together, those results could have important implications for the direction of the economy and the reaction of the Federal Reserve and its approach to interest rate policy, reported CNBC's Jeff Cox.
Meta to invest $14 billion in Scale AIMark Zuckerberg is so frustrated with Meta's standing in artificial intelligence that he's finalizing a deal to invest $14 billion into Scale AI, which would bring its CEO Alexandr Wang into Meta's fold, people familiar with the matter told CNBC. Scale AI helps major tech companies like OpenAI, Google and Microsoft prepare data they use to train cutting-edge AI models.
Google offers buyoutsGoogle on Tuesday offered buyouts to employees in several divisions. Affected units include knowledge and information — which houses the company's search, ads and commerce divisions — and central engineering units as well as marketing, research and communications teams, CNBC has learned. Google has done multiple buyout offers in a few units this year, making it a preferred strategy to reduce headcount.
[PRO] Tesla shares to drop 60%: Wells FargoEven though investors were enthused by the prospect of Tesla rolling out its robotaxi service in the future, Wells Fargo analysts think that feature won't be able to offset the company's weak sales that will trend "meaningfully weaker." The bank expects Tesla's shares to plunge around 63% from Tuesday's close.
AI hits an already weak jobs market in China
China's eagerness to adopt artificial intelligence comes just as economic growth is slowing, putting millions of routine jobs at risk.
"I'm planning to get rid of 360 [Security Technology's] entire marketing department. This way the company can save tens of millions a year," founder and chair Zhou Hongyi said in a Chinese-language video on Friday night, translated by CNBC. It's since been viewed more than 191,000 times on popular Chinese platform Weibo alone.
Whether or not it's just another sales ploy by Zhou, who goes by the moniker "Red Shirt Big Uncle Zhou Hongyi," the video captures an emerging reality: Companies pressured to cut costs may increasingly replace jobs with AI.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Boeing stock slides after Air India 787 Dreamliner crashes
Boeing stock slides after Air India 787 Dreamliner crashes

Yahoo

time39 minutes ago

  • Yahoo

Boeing stock slides after Air India 787 Dreamliner crashes

An Air India Boeing 787 crashed soon after takeoff from Ahmedabad, India, on Thursday. Boeing stock fell sharply in premarket trading. It's thought to be the first crash involving the Dreamliner, which first flew in 2009. Boeing stock fell sharply in premarket trading on Thursday after an Air India plane crashed in what's thought to be the first such incident involving a 787 Dreamliner. The 11-year-old aircraft disappeared from radar shortly after takeoff from the Indian city of Ahmedabad, bound for London Gatwick Airport. There were 242 people on board, Air India said. Rescue efforts are continuing at the crash site. Boeing stock was set to open 7.7% lower as of 8:18 a.m. ET. Neil Wilson, an investor strategist at Saxo UK, said the 787 crash raised serious concerns: "The incident threatens to undermine recent progress in restoring investor and public confidence." GE Aerospace stock fell more than 6% premarket — Boeing is a key customer for jet engines and related services — while Spirit AeroSystems, which makes fuselage and flight deck for Boeing planes, dipped 4%. Boeing closed on Wednesday at $214 and had gained almost 25% this year. The recovery followed Boeing stock ending the year as the biggest loser of the 30 companies on the Dow Jones Industrial Average, shedding 31% last year. Boeing had a painful 2024 following the Alaska Airlines blowout in January. Dave Calhoun stepped down as CEO in March 2024 and was replaced in August by Kelly Ortberg, an industry veteran who signaled a return to prioritizing engineering over profit. First flown in 2009, the 787 was the first next-generation plane produced by a major aircraft manufacturer. It followed the success of the Boeing 777, but it has faced setbacks over the years. Boeing said in a statement: "We are aware of initial reports and are working to gather more information." Read the original article on Business Insider Sign in to access your portfolio

US stock futures fall after Trump raises tariff tensions
US stock futures fall after Trump raises tariff tensions

Yahoo

time39 minutes ago

  • Yahoo

US stock futures fall after Trump raises tariff tensions

U.S. stock futures are lower after President Donald Trump raises tariff tensions again by promising unilateral tariff rates within two weeks. He said he will send letters to trading partners in the next couple of weeks setting unilateral tariff rates, ahead of a July 9 deadline to reimpose higher duties on dozens of economies. Trump's new tariff threat contrasts with the more positive tone officials tried to strike after reaching a trade framework with China in London and earlier remarks from Treasury Secretary Scott Bessent. Bessent said at a hearing before the House Ways and Means Committee that the Trump administration though was open to extending the current 90-day tariff pause beyond July 9 for the U.S.′ top trading partners, as long as they show 'good faith' in ongoing trade negotiations. Futures linked to the blue-chip Dow fell -0.60%, while broad S&P 500 futures dropped -0.41% and tech-heavy Nasdaq futures slipped -0.35.%. Another set of inflation data are due before the opening bell. Producer prices, or the the prices businesses pay for their goods and services, are expected to rise 2.3% on an annual basis in May, according to Bank of America economists. Without the volatile food and energy sectors, producer prices are seen up 2.7%, they said. Some economists expect some tariff-related inflation to appear as inflation first can be seen by businesses, before price increases are passed on to consumers. Oracle's results in the final three months of its fiscal year topped Street views. The company also said cloud infrastructure revenue will rise by more than 70% in fiscal 2026, up from a 50% growth rate in the prior fiscal year. Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday morning. This article originally appeared on USA TODAY: US stock futures fall after Trump raises tariff tensions Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Is Fidelity Select Portfolio Medical Technology and Devices (FSMEX) a Strong Mutual Fund Pick Right Now?
Is Fidelity Select Portfolio Medical Technology and Devices (FSMEX) a Strong Mutual Fund Pick Right Now?

Yahoo

time39 minutes ago

  • Yahoo

Is Fidelity Select Portfolio Medical Technology and Devices (FSMEX) a Strong Mutual Fund Pick Right Now?

If you have been looking for Sector - Health funds, a place to start could be Fidelity Select Portfolio Medical Technology and Devices (FSMEX). FSMEX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like size, cost, and past performance. Zacks categorizes FSMEX as Sector - Health, a segment packed with options. Sector - Health mutual funds offer investors a focus on the healthcare industry, one of the largest sectors in the American economy. These funds can include everything from pharmaceutical companies to medical device manufacturers and for-profit hospitals. Fidelity is responsible for FSMEX, and the company is based out of Boston, MA. Fidelity Select Portfolio Medical Technology and Devices made its debut in April of 1998, and since then, FSMEX has accumulated about $4.48 billion in assets, per the most up-to-date date available. The fund is currently managed by Edward Yoon who has been in charge of the fund since May of 2007. Investors naturally seek funds with strong performance. This fund has delivered a 5-year annualized total return of 5.12%, and it sits in the middle third among its category peers. If you're interested in shorter time frames, do not dismiss looking at the fund's 3 -year annualized total return of 3.37%, which places it in the bottom third during this time-frame. It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Over the past three years, FSMEX's standard deviation comes in at 18.22%, compared to the category average of 15.64%. Over the past 5 years, the standard deviation of the fund is 19.24% compared to the category average of 16.64%. This makes the fund more volatile than its peers over the past half-decade. Investors should note that the fund has a 5-year beta of 0.92, which means it is hypothetically less volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. With a negative alpha of -7.95, managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns. Costs are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, FSMEX is a no load fund. It has an expense ratio of 0.63% compared to the category average of 1.11%. Looking at the fund from a cost perspective, FSMEX is actually cheaper than its peers. While the minimum initial investment for the product is $0, investors should also note that there is no minimum for each subsequent investment. Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included. Overall, Fidelity Select Portfolio Medical Technology and Devices ( FSMEX ) has a high Zacks Mutual Fund rank, and in conjunction with its comparatively similar performance, average downside risk, and lower fees, Fidelity Select Portfolio Medical Technology and Devices ( FSMEX ) looks like a great potential choice for investors right now. Your research on the Sector - Health segment doesn't have to stop here. You can check out all the great mutual fund tools we have to offer by going to to see the additional features we offer as well for additional information. For analysis of the rest of your portfolio, make sure to visit for our full suite of tools which will help you investigate all of your stocks and funds in one place. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (FSMEX): Fund Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store